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Abstract
Background: The burden of cervical cancer and shortage of screening services in Tanzania confers an urgent need for
human papillomavirus (HPV) vaccination. However, the sustainability and impact of another new vaccine campaign in an
under-resourced health system requires consideration. We aimed to determine the impact of the government’s school-
based HPV vaccine campaign in Kilimanjaro region on the provision of routine primary health services and staff workload.
Methods: Data on daily numbers of consultations were collected from health facility register books in 63 dispensaries
and health centres in North-West Tanzania for 20 weeks in 2014. Changes in outpatient, antenatal care (ANC), family
planning (FP) and immunisation service activity levels before, during and after the two HPV vaccination campaigns in
2014 in 30 facilities within Kilimanjaro region (‘intervention facilities’) were compared with changes in activity levels in 33
facilities in Arusha region (‘controls’). Qualitative interviews were conducted with health workers in Kilimanjaro region who
delivered HPV vaccination and those who remained at the facility during in-school HPV vaccine delivery to explore
perceptions of workload and capacity.
Results: Health facility activity levels were low and very variable in both regions. Controlling for district, facility type,
catchment population, clinical staff per 1000 catchment population and the timing of other campaigns, no evidence of a
decrease in consultations at the health facility during HPV vaccination week was found across outpatient, ANC, routine
immunisation and FP services. However, compared to the average week before and after the campaign, health workers
reported longer working hours and patient waiting times, feeling over-stretched and performing duties outside their
normal roles whilst colleagues were absent from the facility conducting the HPV vaccine campaign.
Conclusion: Qualitative interviews with health workers revealed that staff absence from the health facility is
common for a number of reasons, including vaccination campaigns. Health workers perceived that the
absence of their colleagues increased the workload at the health facility. The numbers of consultations for
each service on ‘normal days’ were low and highly variable and there was no clear detrimental effect of the
HPV vaccination campaign on routine health service activity.
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Background
Resource-poor countries carry over 85% of the cervical can-
cer disease burden, the third most common cancer in
women worldwide [1–3]. Screening services are limited
across sub-Saharan Africa [3]. There are two widely li-
censed, safe and efficacious human papillomavirus (HPV)
vaccines targeting two HPV types that cause 70% of cervical
cancer, HPV 16 and 18 [4]. A 9-valent vaccine targeting an
additional 5 oncogenic HPV genotypes has been licensed in
the USA and Europe [4–6]. HPV vaccine delivery is recom-
mended by the World Health Organization (WHO) for 9–
13 year old girls in a two-dose schedule [7]. In 2012 Gavi,
the Vaccine Alliance, announced funding for HPV vaccine
pilot ‘demonstration projects’ or national programmes in
low and middle income countries (LAMICs) [8]. The ma-
jority of HPV vaccine delivery in LAMICs to date has used
campaign-type approaches; nurses from health facilities
visit sites in their catchment area for a set number of days
to deliver each dose to a target population that is often not
routinely targeted for vaccines [7, 9–14].
Introducing a multi-dose vaccine such as the HPV vac-
cine to a novel target population that requires outreach
activities and careful community mobilisation could po-
tentially stress under-resourced health systems and affect
the delivery of other services [14–16]. Four studies in
LAMIC examining the impact of new vaccine introduc-
tions on health systems published limited information on
the impact on routine healthcare activities [17]. However,
several recent studies in The Gambia and Cameroon have
suggested that essential maternal and child health services
and basic outpatient care have been affected during child-
hood vaccine campaigns (e.g. polio, measles) [18–22].
In 2014, the Tanzanian Ministry of Health and Social
Welfare (MoHSW) began a Gavi-supported HPV vaccine
demonstration project using school-based delivery in Kili-
manjaro region, northern Tanzania [8]. Tanzania had only
43.6% of the WHO recommended number of health
workers required to deliver a health service of minimum
quality, with one nurse or midwife per 2300 people and 1
doctor per 32,300 people [23, 24]. Out-of-station activities
by health workers have been shown to lead to task-shifting
and increased work schedules for those staff remaining in
the health facilities [25]. The aim of this study was to deter-
mine the impact of HPV vaccine delivery in Kilimanjaro re-
gion on the provision of routine primary health care
services and health facility staff workload.
Methods
Study design
A retrospective, controlled analysis of health facility data
before, during and after the HPV vaccination campaign
was completed to assess the impact of the campaign
week on levels of routine service provision at the health
facilities. Key informant (KI) interviews with health
workers in facilities involved in HPV vaccine delivery ex-
plored the perceived impact of the vaccine introduction
on the facility and workload.
The HPV vaccine demonstration project
HPV vaccine was delivered in Kilimanjaro region only by
the MoHSW between 3-9th May 2014 (dose 1) and be-
tween 1-7th November 2014 (dose 2), by health facility
nurses in primary schools within their facility catchment
area. Vaccine was offered to all schoolgirls who were in
grade 4 and who were aged 9 years or older. Out-of-school
girls who were aged 9 years were informed by community
mobilisation activities that they were eligible to receive the
vaccine in health facilities.
Study site selection
All government health facilities in Kilimanjaro region were
involved in the demonstration project. Kilimanjaro region
was considered the ‘intervention area’ and neighbouring
Arusha region was the ‘control area’. Of the neighbouring
regions, Arusha region was chosen because it was consid-
ered to be the most similar to Kilimanjaro region in geo-
graphic and socio-economic indicators [26].
Two districts were selected from each region to partici-
pate in the study so that intervention and control areas
were similar with respect to population size and urbanisa-
tion (Table 1). For the quantitative analysis, 33 control
and 30 intervention health facilities (government health
centres or dispensaries) were randomly selected, propor-
tional to the total number of health facilities in each study
district. This ensured data from at least 30 intervention
and control facilities were available for each activity indi-
cator. Assuming a mean of 20 ante-natal care visits per
week in the control facilities and a standard deviation of
10, 30 facilities in each region conferred 80% power to de-
tect a 36% reduction in the number of visits in the inter-
vention clinics in the week of the vaccination campaign.
KI interviews with health workers were completed in a
random sub-set of 12 of the 30 health facilities in Kili-
manjaro region (Table 1). Interviewees were selected on
the day the health facility was visited.
Data collection and analysis
Weekly counts of consultations for four routine activities
were retrospectively collected from facility register books:
outpatient care among children under 5 years (OPD),
Expanded Program on Immunization (EPI) visits, first ante-
natal care (ANC) visits and family planning (FP) consulta-
tions. These were well-defined activities that were routinely
documented in separate register books. For each HPV vac-
cine dose and the equivalent calendar periods in control fa-
cilities, data were collected for 10 weeks, including the
4 weeks preceding and five weeks after the week of HPV
vaccine delivery. Two data collectors entered data into
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Excel. The first author (KEG) validated data entry accuracy
for 5% of register books. The most senior facility staff mem-
ber available provided information on number and cadre of
staff, dates of training, other campaigns and the organisation
of HPV vaccination teams.
The effect of the HPV vaccine campaign week on each
activity indicator was assessed using negative binomial re-
gression in Stata 13.0 (StataCorp; TX, USA), with random
effects to account for the correlation of repeated observa-
tions within facilities. Models were fitted to the weekly
counts of each activity with the clinic’s catchment popula-
tion as an offset. Separate analyses were done on the second
HPV dose. Initial models contained fixed effects for region
(intervention/control), time period (pre-campaign, cam-
paign, post-campaign), and a region - time period inter-
action. Adjusted models included terms for catchment
population, rural/urban location, facility type (centre/dis-
pensary), the number of clinical staff per 1000 catchment
population, and whether other campaigns or training were
conducted in the period of interest, all identified a-priori as
potential confounders. We hypothesised that, if the HPV
vaccine campaign had an impact on activity, the difference
between the intervention and control facilities would differ
by time period (i.e. a significant region – time period inter-
action), and there would be a pattern in the differences in
activity between the weeks before, during and after the
campaign (Fig. 1).
In Kilimanjaro region, 10 KI who delivered HPV vaccine
at schools, and nine who remained at the facility during
HPV vaccination activities were interviewed. After informed
consent, a Tanzanian female research assistant conducted
interviews in Swahili that included questions on health
Table 1 Districts and facilities selected for data collection
Region Selected districts Description and total populationa Total facilitiesb No. selected facilities quantitative
data collection
No. selected facilities
qualitative interviewsc
Kilimanjaro Moshi District Council Semi-urban 466,737 50 17 (4 Health centres, 13 dispensaries) 5
Hai Rural 210,533 38 13 (4 health centres, 9 dispensaries) 7
Arushad Arusha District Council Semi-urban 323,198 27 10 (5 health centres, 5 dispensaries) 0
Meru Rural 268,144 55 23 (5 health centres, 18 dispensaries) 0
aThe United Republic of Tanzania 2012 Population and Housing Census General Report. Dar Es Salaam, Tanzania: National Bureau of Statistics Ministry of Finance
Dar Es Salaam & Office of the Chief Government Statistician Finance Economy and Development Planning Zanzibar, 2012
bTotal number of government health centres or dispensaries in each district obtained from district Ministry of Health and Social Welfare officials
cThe selection of facilities for qualitative data collection was determined by availability of interviewees
d33 health facilities were selected in Arusha region to ensure at least 30 facilities contributed data on each service; register books were missing from 4 facilities for
some services
Fig. 1 Ratios, and 95% confidence intervals, of mean counts of the four activity indicators in intervention facilities compared with control facilities
in the weeks before, during and after HPV vaccine delivery1.1Estimatated by the negative binomial regression model adjusted for district, facility
type (dispensary or health centre), catchment population, total clinical staff per 1000 catchment population per facility, timing of other campaigns
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workers’ perceptions of routine workload, staff capacity and
the impact of the HPV vaccine delivery (Additional files 1
and 2: Figures S3 and S4). Interview data were coded using
Nvivo 10 software (QSR International Pty Ltd. Cardigan,
UK) according to a pre-designed framework of research
questions, new codes were created as they arose. The cod-
ing was conducted by KEG and reviewed by a senior social
scientist, SL. Convergent mixed methods analysis gave equal
weight to each component [27–29].
Results
Across the 63 facilities, a mean of 7 full-time clinical staff
were registered to work per facility (e.g. doctors, nurses,
medical attendants; range 1–61). Intervention and control
facilities had around 1 clinical staff per 1000 population.
The mean catchment population per facility was higher in
Arusha compared to Kilimanjaro (Table 2).
In the 30 Kilimanjaro facilities, on average, vaccin-
ation teams of 3 clinical staff took 3 days to visit 4
primary schools in their catchment area to deliver
each vaccine dose (range 1–6 days; Table 2). The
mean proportion of the workforce absent from the fa-
cility to deliver the vaccine was 50% (range 10%–
100%). In 12 (40%) facilities, 70% or more of the
workforce left the facility to deliver the vaccine. Ad-
ministrative data of the target population of eligible
girls and the number of doses delivered indicated
94.8% mean dose-2 coverage (range across facilities
70–117%; Table 2).
Impact of HPV vaccine delivery on routine services
The average number of consultations per week for under-5
OPD, ANC, EPI and FP services varied considerably across
all time points within facilities in both intervention and con-
trol sites. The under-5 OPD was the busiest service, with a
range of 13–21 consultations per week across pre- and
post-HPV vaccine campaign periods for both doses. There
was a range of 1 to 8 first ANC consultations, 2 to 10 EPI
consultations and 8–24 FP consultations per week. Mean
counts of OPD, ANC, EPI and FP visits per week were
Table 2 Characteristics of health facilities included in the study
Selected facilities included in the study Control region
(Arusha; n = 33)
Intervention region
(Kilimanjaro; n = 30)
Health centres, dispensaries 10, 23 8, 22
Total catchment population (adults and children) 416,606 217,813
Facility characteristics:
Mean catchment population per facility (s.d.) 12,624 (18,423) 7260 (4906)
Range in catchment population per facility 300–75,000 956–22,108
Mean number of clinical staff per facility (s.d.) 6.9 (11.1) 7.0 (5.4)
Range in total number of clinical staff per facility 1–61 2–19
Mean number of primary schools per facility (s.d.) 2.79 (1.54) 4.20 (2.93)
Range in number of primary schools per facility 1–7 1–14
Mean number of clinical doctors per facility per 1000 catchment population (s.d) 0.27 (0.43) 0.25 (0.23)
Mean number of registered nurses per facility per 1000 catchment population (s.d) 0.25 (0.49) 0.31 (0.29)
Mean number of enrolled nurses per facility per 1000 catchment population (s.d.) 0.46 (0.69) 0.36 (1.57)
Mean number of medical attendants per facility per 1000 catchment population (s.d.) 0.14 (0.10) 0.56 (0.43)
Mean total number of clinical staff per facility per 1000 population (s.d.) 0.99 (1.38) 1.10 (0.63)
Mean number of days spent delivering HPV vaccine dose 1 (s.d; range) NA 2.83 (1.12; 1–5)
Mean number of days spent delivering HPV vaccine dose 2 (s.d; range) NA 2.90 (1.45; 1–6)
Mean number of staff on HPV vaccination team doses 1 and 2 (s.d; range) NA 2.53 (1.15; 1–6)
Proportion of total clinical staff workforce involved in HPV vaccination outreach team per facility (s.d) NA 0.50 (0.25; 0.12–1.2)
Mean number of girls targeted in school per facility for dose 1 (s.d; range) NA 65.6 (50.0; 8–242)
Mean number of out of school girls targeted for HPV vaccine per facility for dose 1 (s.d; range) NA 1.2 (3.1; 0–15)
Mean total number of girls targeted for dose 1 per facility (s.d; range) NA 66.8 (50.2; 8–242)
Mean number of doses delivered per facility dose 1 (s.d; range) NA 64.6 (44.3; 9–205)
Mean number of doses delivered per facility dose 2 (s.d; range) NA 63.3 (47.5; 9–196)
Mean coverage per facility dose 1 (s.d; range) NA 103% (28.2; 85–238)
Mean coverage per facility dose 2 (s.d; range) NA 94.8% (9.8; 70–117%)
NA not applicable
Gallagher et al. BMC Health Services Research  (2018) 18:173 Page 4 of 10
lower in the intervention facilities than in the controls dur-
ing the observation periods for both doses (Tables 3 and 4).
In adjusted analyses, there was some evidence of a differ-
ence between intervention and control facilities in the weekly
average number of ANC consultations before, during and
after the dose 1 campaign (p value for interaction =0.026).
However, there was no indication of a pattern over time or
any evidence that the difference between intervention and
control facility activity was greater during the HPV vaccine
campaign week (Table 3; Fig. 1).
In the periods around the second dose, there was strong
evidence that the effect of the time period on OPD and
ANC visits differed between the intervention and control
facilities (p values for interaction = 0.002 and < 0.001, re-
spectively). However, the difference between activity in
intervention and control facilities decreased in the
campaign week (the adjusted ratio of activity between
intervention and control facilities became closer to 1.0)
i.e. the evidence of an interaction was in the opposite dir-
ection to our hypothesis (Table 4; Fig. 1).
When comparing the number of OPD, ANC, EPI and
FP consultations over time within the intervention fa-
cilities alone, accounting for facility characteristics,
there was no evidence of a decrease in consultations
during the HPV vaccine campaign, relative to the
4 weeks pre- or post-campaign, in either the period
around dose 1 or dose 2 (Fig. 2, Additional file 3: Figure
S1). Exploratory analyses stratifying facilities into those
where > 50% or ≤50% of the workforce was absent on
vaccination days found no evidence of a decrease in
average activity during the campaign week in either
stratum (Additional file 4: Figure S2).
Table 3 Impact of the HPV vaccine campaign (dose 1 delivery) on routine services
Dose 1 weeks Number of weeks
control/intervention
Control facilities
mean consults
per week (s.d.)
Intervention facilities
mean consults per
week (s.d.)
Unadjusted RR
p-value
for interaction
Adjusted RR*
p-value
for interaction
Outpatient visits in children under 5 years 0.900 0.978
Pre-Campaign weeks 116/116 16.7 (13.5) 15.3 (10.7) 0.73 (0.52–1.03) 0.62 (0.43–0.90)
Campaign weeks 28/29 13.4 (10.6) 14.9 (12.6) 0.70 (0.46–1.05) 0.63 (0.41–0.98)
Post-campaign weeks 140/145 17.1 (10.5) 17.8 (12.1) 0.72 (0.51–1.00) 0.63 (0.44–0.90)
%change campaign vs pre-campaign −19.8% −2.6%
% change post- vs. pre-campaign + 2.4% + 16.3%
First antenatal care visits 0.018 0.026
Pre-Campaign weeks 116/116 3.2 (4.7) 2.1 (2.2) 1.06 (0.70–1.58) 0.73 (0.45–1.17)
Campaign weeks 29/29 3.1 (3.6) 1.6 (1.7) 0.84 (0.48–1.48) 0.65 (0.34–1.21)
Post-campaign weeks 145/145 4.3 (7.3) 2.0 (2.4) 0.72 (0.49–1.06) 0.48 (0.30–0.77)
%change campaign vs pre-campaign −3.1% −23.8%
% change post- vs. pre-campaign + 34.3% −4.8%
Routine Immunisation visits 0.200 0.341
Pre-Campaign weeks 120/120 7.7 (20.6) 2.4 (2.4) 0.87 (0.62–1.23) 0.66 (0.43–1.01)
Campaign weeks 30/30 7.9 (24.0) 2.3 (2.6) 0.68 (0.42–1.11) 0.60 (0.35–1.04)
Post-campaign weeks 150/150 7.4 (21.0) 2.8 (2.6) 0.98 (0.70–1.36) 0.78 (0.52–1.17)
%change campaign vs pre-campaign + 2.6% −4.2%
% change post- vs. pre-campaign −3.9% + 14.2%
Family Planning consultations 0.792 0.631
Pre-Campaign weeks 124/120 12.4 (14.7) 9.8 (8.2) 1.11 (0.85–1.46) 0.49 (0.34–0.69)
Campaign weeks 31/30 14.6 (18.7) 11.4 (15.9) 1.01 (0.69–1.49) 0.46 (0.30–0.72)
Post-campaign weeks 155/150 16.8 (32.5) 13.8 (15.7) 1.14 (0.87–1.49) 0.53 (0.38–0.75)
%change campaign vs pre-campaign + 17.7% + 16.3%
% change post- vs. pre-campaign + 35.5% + 40.8%
*RR the ratio in the mean number of consultations for each service in the intervention and control facilities in each week, adjusted for district, facility type
(dispensary or health center), catchment population, total clinical staff per 1000 catchment population per facility, timing of other campaigns. P-values for
interaction test the hypothesis that the effect of time period in relation to the HPV vaccination campaign on activity (counts of consultations) differs between the
intervention and control facilities i.e. the campaign weeks have an effect on activity in intervention facilities but not on control facilities
Italicised data indicates the relative change in the number of mean consultations per week, within each region, between the specified time-periods around the
vaccination campaign
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Key informant interviews
The 19 KIs from 12 facilities were aged between 36 and
60 years old, with an average of 12 years’ experience work-
ing as health workers (range 1–31 years). There was over-
lap in different cadres’ reported roles and responsibilities
(Table 5). An enrolled nurse, training to become a regis-
tered nurse, stated:
“I perform all duties; sometimes when the doctor is not
around I have to take over the doctor’s duties”. RV03
Eight KIs from eight facilities reported that their routine
workload was manageable and described having sufficient
capacity to absorb more activities since the facility had ad-
equate staffing levels and/or a small catchment popula-
tion. Three KIs from three health centres indicated a
heavy workload during ‘normal days’ with, insufficient
staff, long waiting times, no time for rest breaks and work-
ing more than routine shifts. Staff absence was only cited
as an issue by two KI:
“….when another person is sick, you are all alone at the
facility, overworking.” RV01
“During measles campaign days we become
overloaded, there is a lot of work.” RV02
During HPV vaccine delivery, some journeys to schools
took 2 h. However, at schools, vaccinators could usually
complete vaccination in half an hour to three hours per
school, depending on the number of eligible girls. Mop-
up activities increased the time that vaccinators spent
Table 4 Impact of the HPV vaccine campaign (dose 2 delivery) on routine services
Dose 2 weeks Number of weeks
control/intervention
Control facilities
mean consults
per week (s.d.)
Intervention facilities
mean consults
per week (s.d.)
Unadjusted RR
p-value for
interaction
Adjusted RR*
p-value for
interaction
Outpatient visits in children under 5 years < 0.001 0.002
Pre-Campaign weeks 120/120 19.1 (20.7) 13.3 (10.1) 1.37 (0.97–1.91) 0.50 (0.32–0.79)
Campaign weeks 32/30 15.6 (19.3) 13.0 (9.7) 1.69 (1.14–2.50) 0.72 (0.44–1.19)
Post-campaign weeks 160/146 16.8 (15.0) 14.6 (10.0) 1.92 (1.38–2.69) 0.62 (0.40–0.98)
%change campaign vs pre-campaign −18.3% −2.3%
% change post- vs. pre-campaign −12.0% + 9.8%
First antenatal care visits < 0.001 < 0.001
Pre-Campaign weeks 116/116 5.2 (14.0) 1.8 (1.9) 0.81 (0.54–1.21) 0.59 (0.37–0.96)
Campaign weeks 30/29 4.1 (7.4) 3.0 (3.6) 1.59 (0.97–2.62) 1.23 (0.68–2.22)
Post-campaign weeks 150/145 7.9 (24.9) 2.0 (2.5) 0.61 (0.41–0.91) 0.50 (0.32–0.80)
%change campaign vs pre-campaign −21.2% + 66.7%
% change post- vs. pre-campaign + 51.9% + 11.1%
Routine Immunisation visits 0.585 0.659
Pre-Campaign weeks 124/120 7.9 (19.8) 2.3 (2.4) 0.82 (0.59–1.14) 0.57 (0.38–0.86)
Campaign weeks 31/30 9.1 (21.0) 2.8 (3.0) 0.93 (0.59–1.46) 0.70 (0.42–1.19)
Post-campaign weeks 155/150 6.4 (15.1) 2.2 (2.6) 0.94 (0.68–1.31) 0.62 (0.41–0.93)
%change campaign vs pre-campaign + 15.2% + 21.7%
% change post- vs. pre-campaign −19.0% −4.3%
Family Planning consultations 0.424 0.499
Pre-Campaign weeks 124/120 13.2 (18.8) 11.3 (11.5) 1.06 (0.80–1.40) 0.58 (0.42–0.79)
Campaign weeks 31/30 10.5 (10.1) 9.1 (7.7) 1.26 (0.83–1.91) 0.60 (0.37–0.95)
Post-campaign weeks 155/150 17.2 (21.0) 13.9 (19.8) 0.97 (0.75–1.27) 0.50 (0.36–0.69)
%change campaign vs pre-campaign −20.5% −19.5%
% change post- vs. pre-campaign + 30.3% + 23.0%
*RR the ratio in the mean number of consultations for each service in the intervention and control facilities in each week, adjusted for district, facility type
(dispensary or health center), catchment population, total clinical staff per 1000 catchment population per facility, timing of other campaigns. P-values for
interaction test the hypothesis that the effect of time period in relation to the HPV vaccination campaign on activity (counts of consultations) differs between the
intervention and control facilities i.e. the campaign week has an effect on activity in intervention facilities but not on control facilities
Italicised data indicates the relative change in the number of mean consultations per week, within each region, between the specified time-periods around the
vaccination campaign
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away from the facility; up to four visits per school were
conducted to reach girls who were initially absent from
school, or refused vaccination:
“Students may dodge from school, this led to the
addition of more than those two or three planned
days; they went for four days” RNV06
Vaccinator KIs reported that sensitisation was more dif-
ficult and time-consuming for HPV vaccine compared to
other vaccines because there was a low level of aware-
ness about HPV and cervical cancer. However, it was
clear that staff perceived the workload to deliver the
HPV vaccine was less than that of other campaigns as it
was a smaller target population:
“For example, for that national measles rubella
campaign almost all staff were out of the facility” RNV04
Regarding the perceived impact of HPV vaccine introduc-
tion on routine activities, all nine KIs who stayed at their
nine facilities during HPV vaccine activities stated that the
campaign increased their workload and they had to em-
ploy strategies to cope with the staff shortage. These in-
cluded task-shifting and working several hours longer
each day (reported by 8 KIs), or deferring less urgent pa-
tients to the next day (1 KI). All but one KI reported that
staff were not allowed to take leave during campaigns.
“We have a person for every department but sometimes
you find that two or three departments were attended
by only a single person [during HPV vaccine delivery].
Sometimes you can be tired but just work because there
is no way out” RNV01
Four KI reported that patients had to wait substantially
longer to be seen. Only one KI stated that there was no
impact of HPV vaccine delivery on routine service
provision, despite having to close the facility to deliver
the vaccine in-schools, and attributed this to the fact
that the facility had a small catchment population. No
KI perceived that the HPV vaccine sensitisation activities
in the community affected the uptake of other routine
vaccines, or dissuaded patients from coming to the facil-
ity during the campaign week. KI reported that the ac-
curacy of recording data in register books did not
change during the campaigns.
KI were positive about the benefits of the HPV vaccine
to the community and, despite the additional workload,
many wanted to expand the target age group in order to
protect more women. Overall, health workers involved
in HPV vaccine activities supported school-based deliv-
ery, despite the transport issues and the increased work-
load because they could access more girls in schools and
teachers could assist in sensitisation. They believed rely-
ing on facility-based delivery would lead to children
Fig. 2 Ratios, and 95% confidence intervals, of mean counts of the four activity indicators during dose 1 delivery, comparing the weeks before
and after the vaccine campaign with week 5 (HPV vaccine campaign week), or the equivalent time periods in control facilities1. 1Estimatated by
the negative binomial regression model adjusted for district, facility type (dispensary or health centre), catchment population, total clinical staff
per 1000 catchment population per facility, timing of other campaigns
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absconding, or the distance between the facility and
household being a barrier to vaccination.
Discussion
Despite the human resource and health service con-
straints in Tanzania, at the current level of healthcare
utilization, we found no evidence that the first year of an
HPV vaccine school-based campaign in Kilimanjaro re-
gion affected the provision of consultations for routine
outpatient, ANC, EPI and FP services during the HPV
campaign week. A study in Rwanda also found no im-
pact of HPV vaccine introduction on the provision of
ANC services [30], although Rwanda has a relatively
well-resourced health system in comparison to the rest
of the region [12, 24]. There is some suggestion from
our qualitative research that the quality of care provided
at the facility during the HPV vaccine campaign could
have been affected, with longer patient waiting times
and staff performing some tasks outside their normal
responsibilities.
The school-based ‘campaign’ delivery approach resulted
in two to three health workers, half of an average facility’s
workforce, leaving the facility to conduct outreach in
schools for 3 days, twice in the year. The strategy led to
very high vaccine coverage. Health workers mitigated the
impact of staff absence on the provision of routine ser-
vices at the facility despite the general shortage of health
workers. The predominant mitigation strategies were to
postpone annual leave, to work longer hours and to task-
shift. It was common for enrolled nurses to perform the
same tasks as registered (fully trained) nurses with or
without supervision; this has been reported in previous
studies [25, 31].
The size of the facility catchment populations and Tan-
zania’s crude birth rate of 38.1 births per 1000 population
per year [26], leads us to expect at least double the num-
ber of ANC appointments than the two visits observed
per week. The low level of utilisation and concentration of
patient attendance in the morning hours is consistent with
existing literature and could have contributed to our find-
ings of a lack of impact of the campaign week on the
number of routine consultations [31, 32].
The strengths of this study include the mixed methods
design which allowed conclusions to be drawn with
greater plausibility than would have been possible using
either of the methods alone. The availability of data pre-,
post-, and during the campaign week and the timing of
this study should have limited recall bias [27]. The data
collection team observed consistent use of register books
during data collection activities. Qualitative data were
analysed prior to quantitative data to avoid bias in the
interpretation of transcripts. A range of experiences
were captured at facilities with variable staffing levels
and locations.
There were several limitations to this study. The ex-
tent of an impact on the quality of care, suggested by
the qualitative research, was difficult to measure retro-
spectively. A substantial level of health worker absentee-
ism on ‘normal days’ has been reported in Tanzania [31].
Although KIs reported a reduction in health workers
during campaign days, it is unclear how significant this
impact was since patterns of staff absenteeism on ‘non-
campaign’ days were not measured. Additionally, quanti-
tative analysis could not control for absenteeism during
ad-hoc outreach activities which were described in quali-
tative interviews but had no recorded dates.
We focused on four services at the clinic level. It is
conceivable that HPV vaccine introduction could have
affected a different selection of services at different
facilities depending on the vaccinator nurses’ different
roles. Kilimanjaro region may not be representative of
the potential impact of vaccine introduction on health
services nationwide since the region has a 10 per
10,000 ratio of health workers to population, com-
pared to the national average of 7 per 10,000 and 4
per 10,000 in several regions [23, 25, 33].
Table 5 Key informant designation
Reported
designation
HPV
vaccinators
Non-
vaccinators
Reported roles and
responsibilities
Doctor 1 2 Supervision of all services
and cleanliness, general
administration of the facility,
minor operations, referrals.
Management of outpatient
and reproductive and child
health care.
Matron 0 1 Coordination of facility activities
and colleagues, in-patient and
out-patient care, MCH duties.
Registered
nurse
2 2 Supervision of colleagues,
provision of all services
including delivery care, family
planning, ANC, vaccinations,
education, dispensing drugs.
Midwife 1 0 MCH, reproductive health.
Enrolled
nurse
1 1 Vaccinations, under-5
outpatient services, dispensary,
health education, MCH services,
family planning, and outreach.
Auxiliary
nurse
1 0 Assist every department.
Medical
attendant/
MCH aider
4 3 Dispense drugs, dress wounds,
vaccinations, assist ANC, delivery
care, under-5 outpatient care,
HIV VCT, and other reproductive
health care, cleaning the facility.
Total 10 9
ANC Antenatal care, HIV VCT human immunodeficiency virus voluntary
counseling and testing, MCH Maternal and child health
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Conclusion
Qualitative interviews revealed that staff absence from the
health facility is common for a number of reasons and
health workers perceived that the absence of colleagues
increased their workload. The numbers of consultations
for each service on ‘normal’ (non-campaign) days were
low and highly variable. We found no evidence that the
absence of staff from the facility on HPV vaccine cam-
paign weeks corresponded to a decrease in the number of
consultations for routine services at the health facility
when compared to non-campaign weeks, controlling for
district, facility type, catchment population, clinical staff
per 1000 catchment population and the timing of other
formal campaigns. Further research on the impact of cam-
paigns on health services is still necessary in order to
determine their sustainability.
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